Q2 2022 13F Holders as of 30 Jun 2022
-
Type / Class
-
Equity / Common Stock, par value $0.001 per share
-
Shares outstanding
-
79.6M
-
Number of holders
-
27
-
Total 13F shares, excl. options
-
6.53M
-
Shares change
-
-470K
-
Total reported value, excl. options
-
$15.9M
-
Value change
-
-$1.24M
-
Put/Call ratio
-
0
-
Number of buys
-
4
-
Number of sells
-
-14
-
Price
-
$2.44
Significant Holders of Eledon Pharmaceuticals, Inc. - Common Stock, par value $0.001 per share (ELDN) as of Q2 2022
33 filings reported holding ELDN - Eledon Pharmaceuticals, Inc. - Common Stock, par value $0.001 per share as of Q2 2022.
Eledon Pharmaceuticals, Inc. - Common Stock, par value $0.001 per share (ELDN) has 27 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 6.53M shares
of 79.6M outstanding shares and own 8.2% of the company stock.
Largest 10 shareholders include BVF INC/IL (2.33M shares), Cormorant Asset Management, LP (1.31M shares), VANGUARD GROUP INC (679K shares), Woodline Partners LP (517K shares), Point72 Asset Management, L.P. (428K shares), Ikarian Capital, LLC (363K shares), CM Management, LLC (225K shares), GEODE CAPITAL MANAGEMENT, LLC (129K shares), Ensign Peak Advisors, Inc (77.1K shares), and Eversept Partners, LP (59.1K shares).
This table shows the top 27 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.